Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Aged Julia Creek dunnarts suffer from reproductive and hormonal issues, aiding conservation efforts.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

PRP injections may be an effective treatment for severe hair loss.

Ritlecitinib works well and is safe for treating alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

HVDRR is caused by VDR gene mutations, leading to vitamin D resistance, treatable with high calcium doses, but alopecia remains permanent.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Hyaluronic acid injections can cause serious artery blockages, so practitioners must be careful.

Ritlecitinib can help about 14,000 people with severe hair loss.

The infant was diagnosed with Rothmund-Thomson syndrome, a rare genetic disorder causing various physical and developmental issues.

A gene mutation causes curly hair and hair loss in rats.

Red light therapy temporarily increased blood flow in the eye but didn't change other eye structures.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Alopecia areata does not affect areas with psoriasis plaques.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Red-light therapy may slow myopia progression better than traditional treatments.

The method greatly improves low-light sports images' quality and reduces artifacts.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

A new syndrome, Teelwani Syndrome, combines features of two rare genetic disorders.

The new microrhizotron tool effectively observes and measures pepper plant roots non-destructively.

5-ARI therapy may help prevent prostate cancer progression.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.